CRISI Medical Systems

About

CRISI Medical Systems is developing innovative drug-delivery systems designed to improve clinical outcomes and lower healthcare costs by making the administration of intravenous (IV) drugs safer, more accurate, and more cost-effective. CRISI's systems are focused on manually injected drugs, which account for roughly half of the 1.3 billion IV medication doses administered annually in the United States. CRISI was acquired by Becton Dickinson (NYSE: BDX).